Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Distal Airway Dysbiosis Present in Early RA

Microbiome; ePub 2016 Nov 17; Scher, et al

Distal airway dysbiosis is present in untreated early rheumatoid arthritis (RA) and similar to that detected in sarcoidosis lung inflammation, according to a recent study. This community perturbation, which correlates with local and systemic autoimmune/inflammatory changes, may potentially drive initiation of RA in a proportion of cases. Researchers utilized 16S rRNA gene high-throughput sequencing to compare the bacterial community composition of bronchoalveolar lavage fluid (BAL) in patients with early, disease-modifying anti-rheumatic drugs (DMARD)-naïve RA, patients with lung sarcoidosis, and healthy control subjects. Samples were further assessed for the presence and levels of anti-citrullinated peptide antibodies (including fine specificities) in both BAL and serum. They found:

  • The BAL microbiota of RA patients was significantly less diverse and abundant when compared to healthy controls, but similar to sarcoidosis patients.
  • This distal airway dysbiosis was attributed to the reduced presence of several genus (ie, Actynomyces and Burkhordelia) as well as reported periodontopathic taxa, including Treponema, Prevotella, and Porphyromonas.

Citation:

Scher JU, Joshua V, Artacho A, et al. The lung microbiota in early rheumatoid arthritis and autoimmunity. [Published online ahead of print November 17, 2016]. Microbiome. doi:10.1186/s40168-016-0206-x.